Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Differentiated thyroid carcinoma referred for radioiodine therapy

Ibrahim A. Al-Balawi, Hadir M. Meir, Mohammed K. Yousef, Hala A. Nayel and Mohammed F. Al-Mobarak
Saudi Medical Journal June 2001, 22 (6) 497-503;
Ibrahim A. Al-Balawi
Department of Surgery, King Abdul Aziz Hospital & Oncology Center, Jeddah, Kingdom of Saudi Arabia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hadir M. Meir
Department of Oncology, King Abdul Aziz Hospital & Oncology Center, PO Box 31467, Jeddah 21497, Kingdom of Saudi Arabia. Fax. +966 (2) 6379811.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed K. Yousef
Department of Oncology, King Abdul Aziz Hospital & Oncology Center, Jeddah, Kingdom of Saudi Arabia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hala A. Nayel
Department of Oncology, King Abdul Aziz Hospital & Oncology Center, Jeddah, Kingdom of Saudi Arabia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed F. Al-Mobarak
Department of Internal Medicine, King Abdul Aziz Hospital & Oncology Center, PO Box 31467, Jeddah 21497, Kingdom of Saudi Arabia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE: The current work was conducted to study the disease status and treatment results of patients with differentiated thyroid carcinoma referred for radioactive iodine therapy.

METHODS: Retrospective review of 78 patients with differentiated thyroid carcinoma referred for radioiodine therapy in the Nuclear Medicine Unit, King Abdulaziz Hospital and Oncology Center, Jeddah, Kingdom of Saudi Arabia. Analysis of the clinicopathologic characteristics, age correlation to different risk factors, treatment protocol and results were performed.

RESULTS: Seventy seven percent were female and the female to male ratio was 3.5:1. The age of patients ranged between 13-63 years with a median age of 36 years. Cervical lymph node involvement was detected in 22 patients (25%). Papillary carcinoma was encountered in 78 patients (90%) and follicular carcinoma in 9 patients (10%). Analysis of the clinicopathologic characteristics showed no statistically significant difference between patients in the different age groups except for extrathyroid extension and lymph node involvement. Patients older than 45 years had a statistically significant lower incidence of nodal involvement and higher incidence of extra thyroid extension (P<0.02). In the current study we used a high dose method (Radioiodine-131 dose 75-100mCi) for thyroid remnant ablation after thyroidectomy (total or near total) in 67 patients. An Iodine 131 dose of 150 mCi was used in 12 patients with radioiodine-avid cervical lymph nodes and in 3 patients with gross residual tumor. In 4 patients with distant metastases an Iodine 131 dose of 200 mCi was used. For the whole study group the 5 year overall survival and disease-free survival was 96% and 88%.

CONCLUSION: The current study, as with many other retrospective studies, concluded that despite the fact that differentiated thyroid carcinoma is among the most curable cancers, some patients are still at high risk for recurrent disease and associated mortality.

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 22 (6)
Saudi Medical Journal
Vol. 22, Issue 6
1 Jun 2001
  • Table of Contents
  • Cover (PDF)
  • Index by author
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differentiated thyroid carcinoma referred for radioiodine therapy
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Differentiated thyroid carcinoma referred for radioiodine therapy
Ibrahim A. Al-Balawi, Hadir M. Meir, Mohammed K. Yousef, Hala A. Nayel, Mohammed F. Al-Mobarak
Saudi Medical Journal Jun 2001, 22 (6) 497-503;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differentiated thyroid carcinoma referred for radioiodine therapy
Ibrahim A. Al-Balawi, Hadir M. Meir, Mohammed K. Yousef, Hala A. Nayel, Mohammed F. Al-Mobarak
Saudi Medical Journal Jun 2001, 22 (6) 497-503;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The interaction between no folic acid supplementation during early pregnancy and preeclampsia increased the risk of preterm birth
  • The characteristics of Grave’s disease in children and adolescent patients in Al-Madinah Al-Munawwarah
  • Patellar height changes after treatment of tibia plateau fractures
Show more Original Article

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2023 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire